Joint Pain and Regenerative Medicine: A Physician's Perspective

Joint pain is the most common reason patients contact our centre, and it is also the area where expectations most often need adjusting. This article sets out how we assess a painful joint, where regenerative therapy genuinely helps, and where the honest answer is a referral to a surgeon.

Start with the diagnosis, not the therapy

Patients frequently arrive asking for a specific injection. That is the wrong starting point. A painful knee might be cartilage wear, meniscal irritation, ligament laxity, referred pain from the hip, or inflammatory arthritis — and each of those responds differently. Injecting before establishing the cause is guesswork with a needle.

Our assessment includes history, physical examination, review of any existing imaging and, where necessary, new imaging. We are looking for how much viable tissue remains, whether the joint is mechanically stable, and whether inflammation is local or systemic.

Where regenerative therapy performs well

The best responders share a pattern: early to moderate degeneration, remaining cartilage, a mechanically stable joint and reasonable general health. In these patients, platelet and cellular protocols can reduce inflammatory activity inside the joint, improve comfort and — in the studies with longer follow-up — appear to slow further deterioration.

Tendon problems around the joint also respond well. Chronic tendon irritation is a failure of repair rather than a failure of anti-inflammatory medication, which is precisely what growth factor and platelet protocols address.

Where it does not

In advanced osteoarthritis with bone-on-bone contact, significant deformity or a collapsed joint surface, no injection restores the structure. Some patients gain temporary comfort, but the mechanical problem remains mechanical. In those cases we say so and recommend orthopaedic surgical review — and we recognise that this conversation costs the clinic a sale. We consider that the price of practising honestly.

Similarly, if joint pain reflects an untreated inflammatory or autoimmune condition, the priority is proper rheumatological management, not a regenerative program layered on top of an unaddressed diagnosis.

What treatment actually involves

For a straightforward joint, treatment may be a single platelet session with review at six weeks. For more involved cases we combine intra-articular cellular therapy with systemic anti-inflammatory infusions across a three to five day program. Injections are placed under guidance where accuracy matters, and every plan is written down with its cost before anything begins.

Recovery expectations

Most patients feel mild soreness for a few days — a normal inflammatory response, not a complication. Meaningful change typically appears between weeks four and twelve. We ask patients to keep moving within comfort, because loading is part of how joint tissue remodels; complete rest is counterproductive.

How to judge a clinic

• Does a licensed physician examine you, or does a salesperson quote you?
• Are you given a written plan with a total cost before payment?
• Has anyone described a scenario in which this would not work for you?
• Is follow-up scheduled and included?
• Would they refer you to a surgeon if that were the better option?

If your joints are limiting how you live, send us your recent imaging on WhatsApp. A physician will tell you frankly whether a regenerative program is worth your time — including when it is not.